Envestnet Asset Management Inc. Buys 2,322 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Envestnet Asset Management Inc. lifted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVAGet Rating) by 5.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,374 shares of the company’s stock after acquiring an additional 2,322 shares during the period. Envestnet Asset Management Inc.’s holdings in Privia Health Group were worth $1,292,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in shares of Privia Health Group by 16.2% during the first quarter. Vanguard Group Inc. now owns 4,255,881 shares of the company’s stock worth $113,759,000 after acquiring an additional 593,178 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of Privia Health Group by 34.1% during the first quarter. Bank of New York Mellon Corp now owns 4,138,080 shares of the company’s stock worth $110,611,000 after acquiring an additional 1,052,856 shares in the last quarter. BlackRock Inc. increased its position in shares of Privia Health Group by 108.4% during the first quarter. BlackRock Inc. now owns 2,579,166 shares of the company’s stock worth $68,940,000 after acquiring an additional 1,341,730 shares in the last quarter. Riverbridge Partners LLC increased its position in shares of Privia Health Group by 1.5% during the second quarter. Riverbridge Partners LLC now owns 2,080,967 shares of the company’s stock worth $60,598,000 after acquiring an additional 31,010 shares in the last quarter. Finally, Principal Financial Group Inc. increased its position in shares of Privia Health Group by 4.5% during the first quarter. Principal Financial Group Inc. now owns 1,051,624 shares of the company’s stock worth $28,109,000 after acquiring an additional 45,635 shares in the last quarter. Institutional investors own 62.81% of the company’s stock.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA opened at $22.82 on Tuesday. The company’s 50-day moving average is $33.16 and its 200 day moving average is $32.13. The company has a market capitalization of $2.61 billion, a P/E ratio of -63.39 and a beta of 0.99. Privia Health Group, Inc. has a fifty-two week low of $17.99 and a fifty-two week high of $44.64.

Privia Health Group (NASDAQ:PRVAGet Rating) last issued its quarterly earnings results on Thursday, November 10th. The company reported $0.01 EPS for the quarter. The business had revenue of $342.90 million for the quarter, compared to analysts’ expectations of $323.66 million. Privia Health Group had a negative net margin of 3.02% and a negative return on equity of 6.82%. As a group, research analysts predict that Privia Health Group, Inc. will post -0.25 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on PRVA shares. BTIG Research increased their target price on shares of Privia Health Group to $45.00 in a report on Monday, August 15th. Piper Sandler reduced their target price on shares of Privia Health Group to $42.00 in a report on Thursday, November 17th. Truist Financial cut their price target on shares of Privia Health Group to $41.00 in a research note on Thursday, November 17th. Guggenheim increased their price target on shares of Privia Health Group from $36.00 to $51.00 and gave the company a “buy” rating in a research note on Friday, August 12th. Finally, Canaccord Genuity Group cut their price target on shares of Privia Health Group from $50.00 to $43.00 in a research note on Friday, November 11th. Eleven equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $41.08.

Insider Transactions at Privia Health Group

In related news, CEO Matthew Shawn Morris sold 68,102 shares of the company’s stock in a transaction that occurred on Thursday, August 25th. The shares were sold at an average price of $42.20, for a total value of $2,873,904.40. Following the transaction, the chief executive officer now directly owns 121,739 shares in the company, valued at $5,137,385.80. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Privia Health Group news, CEO Matthew Shawn Morris sold 68,102 shares of the company’s stock in a transaction on Thursday, August 25th. The stock was sold at an average price of $42.20, for a total value of $2,873,904.40. Following the transaction, the chief executive officer now owns 121,739 shares of the company’s stock, valued at approximately $5,137,385.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Parth Mehrotra sold 138,547 shares of the company’s stock in a transaction on Monday, September 19th. The stock was sold at an average price of $37.84, for a total value of $5,242,618.48. Following the sale, the chief operating officer now owns 97,391 shares of the company’s stock, valued at $3,685,275.44. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,290,515 shares of company stock valued at $45,284,372. Insiders own 57.60% of the company’s stock.

Privia Health Group Profile

(Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Articles

Institutional Ownership by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.